Sage Therapeutic Stock Price Prediction
| SAGE Stock | USD 7.49 0.18 2.46% |
Momentum 62
Buy Extended
Oversold | Overbought |
EPS Estimate Next Quarter (1.16) | EPS Estimate Current Year (3.67) | EPS Estimate Next Year (2.53) | Wall Street Target Price 8.2253 | EPS Estimate Current Quarter (1.36) |
Using Sage Therapeutic hype-based prediction, you can estimate the value of Sage Therapeutic from the perspective of Sage Therapeutic response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Sage Therapeutic using Sage Therapeutic's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Sage using crowd psychology based on the activity and movement of Sage Therapeutic's stock price.
Sage Therapeutic Implied Volatility | 1.53 |
Sage Therapeutic's implied volatility exposes the market's sentiment of Sage Therapeutic stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Sage Therapeutic's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Sage Therapeutic stock will not fluctuate a lot when Sage Therapeutic's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Sage Therapeutic to buy its stock at a price that has no basis in reality. In that case, they are not buying Sage because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Sage Therapeutic after-hype prediction price | USD 7.49 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sage |
Sage Therapeutic After-Hype Price Prediction Density Analysis
As far as predicting the price of Sage Therapeutic at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Sage Therapeutic or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Sage Therapeutic, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Sage Therapeutic Estimiated After-Hype Price Volatility
In the context of predicting Sage Therapeutic's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Sage Therapeutic's historical news coverage. Sage Therapeutic's after-hype downside and upside margins for the prediction period are 2.01 and 12.97, respectively. We have considered Sage Therapeutic's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Sage Therapeutic is relatively risky at this time. Analysis and calculation of next after-hype price of Sage Therapeutic is based on 3 months time horizon.
Sage Therapeutic Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Sage Therapeutic is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sage Therapeutic backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Sage Therapeutic, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.65 | 5.55 | 0.01 | 0.24 | 6 Events / Month | 14 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
7.49 | 7.49 | 0.00 |
|
Sage Therapeutic Hype Timeline
Sage Therapeutic is at this time traded for 7.49. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of 0.24. Sage is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.65%. %. The volatility of related hype on Sage Therapeutic is about 1492.67%, with the expected price after the next announcement by competition of 7.73. About 80.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.97. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sage Therapeutic has Price/Earnings To Growth (PEG) ratio of 0.74. The entity recorded a loss per share of 6.59. The firm had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 6 days. Check out Sage Therapeutic Basic Forecasting Models to cross-verify your projections.Sage Therapeutic Related Hype Analysis
Having access to credible news sources related to Sage Therapeutic's direct competition is more important than ever and may enhance your ability to predict Sage Therapeutic's future price movements. Getting to know how Sage Therapeutic's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Sage Therapeutic may potentially react to the hype associated with one of its peers.
Sage Therapeutic Additional Predictive Modules
Most predictive techniques to examine Sage price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sage using various technical indicators. When you analyze Sage charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Sage Therapeutic Predictive Indicators
The successful prediction of Sage Therapeutic stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Sage Therapeutic, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Sage Therapeutic based on analysis of Sage Therapeutic hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Sage Therapeutic's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Sage Therapeutic's related companies. | 2022 | 2023 | 2024 | 2025 (projected) | Graham Number | 63.5 | 52.16 | 33.7 | 35.66 | Receivables Turnover | 0.56 | 1.02 | 0.92 | 0.51 |
Story Coverage note for Sage Therapeutic
The number of cover stories for Sage Therapeutic depends on current market conditions and Sage Therapeutic's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Sage Therapeutic is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Sage Therapeutic's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Sage Therapeutic Short Properties
Sage Therapeutic's future price predictability will typically decrease when Sage Therapeutic's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Sage Therapeutic often depends not only on the future outlook of the potential Sage Therapeutic's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sage Therapeutic's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 60.8 M | |
| Cash And Short Term Investments | 504.4 M |
Complementary Tools for Sage Stock analysis
When running Sage Therapeutic's price analysis, check to measure Sage Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sage Therapeutic is operating at the current time. Most of Sage Therapeutic's value examination focuses on studying past and present price action to predict the probability of Sage Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sage Therapeutic's price. Additionally, you may evaluate how the addition of Sage Therapeutic to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |